Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins

Endocrinology

Volumn 138, Issue 4, 1997, Pages 1427-1433

  Párrizas, Marcelina ^a   Gazit, Aviv ^b   Levitzki, Alexander ^b   Wertheimer, Efrat ^c   Leroith, Derek ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

3 BROMO 5 TERT BUTYL 4 HYDROXYBENZYLIDENEMALONONITRILE; 5 (2 BENZOTHIAZOLYL)THIOMETHYL 4 HYDROXY 3 METHOXYBENZYLIDENECYANOACETAMIDE; AG 1034; AG 1049; AG 1500; AG 1557; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR KINASE; PROTEIN TYROSINE KINASE INHIBITOR; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TYRPHOSTIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CELL PROLIFERATION; CELL STRAIN 3T3; CONTROLLED STUDY; ENZYME INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030909657     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.4.5092     Document Type: Article

References (29)

1. Ullrich A, Bell JR, Chen EY, Herrera R, Petruzelli LM, Dull TJ, Gray A, Coussens L, Liao YC, Tsubokawa M, Mason A, Seeburg PH, Grunfeld C, Rosen OM, Ramachandran J 1985 Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313:756-760
2. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, LeBon T, Kathuria S, Chen E, Jacobs S, Francke U, Ramachandran J, Fujita-Yamaguchi Y 1986 Insulin-like growth factor-1 receptor primary structure: comparison with insulin receptor suggest structural determinants that define functional specificity. EMBO J 5:2503-2512
3. LeRoith D, Sampson PC, Roberts Jr CT 1994 How does the mitogenic insulin-like growth factor-1 receptor differ from the metabolic insulin receptor? Horm Res 41 [Suppl 2]:74-79
4. Hernández-Sáncher C, Blakesley VA, Kalebic T, Helman L, LeRoith D 1995 The role of the tyrosine kinase domain of the insulin-like growth factor-1 receptor in intracellular signaling, cellular proliferation, and tumorigenesis. J Biol Chem 270:29176-29181
5. Resnicoff M, Burgaud JL, Rotman D, Abraham D, Baserga R 1995 Insulin-like growth factor-1 receptor. its role in cell proliferation, apoptosis and tumorigenicity. Lab Invest 73:311-331
6. Rodríguez-Tarduchy G, Collins MKL, Garcia I, López-Rivas A 1992 Insulin-like growth factor-1 inhibits apoptosis in interleukin-3-dependent hemopoietic cells. J Immunol 149:535-540
7. Párrizas M, Saltiel AR, LeRoith D 1997 Insulin-like growth factor-1 inhibits apoptosis using the phosphatidyl-inositol 3′ kinase pathway and the MAP kinase pathway. J Biol Chem 272:154-161
8. Gottschalk WK 1991 The pathway mediating insulin's effects on pyruvate dehydrogenase bypasses the insulin receptor tyrosine kinase. J Biol Chem 266:8814-8819
9. Rafaeloff R, Maddux BA, Brunetti A, Sbraccia P, Sung CK, Patel R, Hawley DM, Goldfine ID 1991 Transmembrane signaling by insulin via an insulin receptor mutated at tyrosines 1158, 1162 and 1163. Biochem Biophys Res Commun 179:912-918
10. Kato H, Faria TN, Stannard B, Roberts Jr CT, LeRoith D 1993 Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-1 (IGF-1) receptor. J Biol Chem 268:2655-2661
11. Blakesley VA, Kato H, Roberts Jr CT, LeRoith D 1995 Mutation of a conserved amino acid residue (tryptophan 1173) in the tyrosine kinase domain of the IGF-1 receptor abolishes autophosphorylation but does not eliminate biologic function. J Biol Chem 270:2764-2769
12. Bishop JM 1987 The molecular genetics of cancer. Science 235:305-311
13. Levitzki A, Gazit A 1995 Tyrosine kinase inhibition: an approach to drug development. Science 267:1782-1788
14. Osherov N, Gazit A, Gilon C, Levitzki A 1993 Selective inhibition of the epidermal growth factor and HER2/Neu receptors by tyrphostins. J Biol Chem 268:11134-11142
15. Ohmichi M, Pang L, Ribon V, Gazit A, Levitzki A, Saltiel AR 1993 The tyrosine kinase inhibitor tyrphostin blocks the cellular actions of nerve growth factor. Biochemistry 32:4650-4658
16. Gazit A, Chen J, App H, MacMahon G, Hirth P, Chen I, Levitzki A1996 Higly potent inhibitors of EGF receptor kinase. SAR study of 4-amilidoquinazolines. Bioorg Med Chem 4:1203-1207
17. Wertheimer E, Barbetti F, Muggeo M, Roth J, Taylor SI 1994 Two mutations in a conserved structural motif in the insulin receptor inhibit normal folding and intracellular transport of the receptor. J Biol Chem 269:7587-7592
18. Cook PW, Pittelkow MR, Keeble WW, Graves-Deal R, Coffey RJ, Shipley GD 1992 Amphiregulin mRNA is elevated in psoriatic epidermis and gastro-intestinal carcinomas. Cancer Res 52:3224-3227
19. Ross R 1993 The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809
20. Werner H, Re GG, Drummond IA, Sukhatme VP, Rauscher FJ, Sens DA, Garvin AJ, LeRoith D, Roberts Jr CT 1993 Increased expression of the insulin-like growth factor-1 receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. Proc Natl Acad Sci USA 90:5828-5832
21. Harrington EA, Bennett MR, Fanidi A, Evan GI 1994 C-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 13:3286-3295
22. D'Mello SR, Galli C, Ciotti T, Calissano P 1993 Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor 1 and cAMP. Proc Natl Acad Sci USA 90:10989-10993
23. Yaish P, Gazit A, Gilon C, Levitzki A 1988 Blocking of EGF- dependent cell proliferation by EGF receptor kinase inhibitors. Science 242:933-935
24. Kovalenko M, Gazit A, Bohmer A, Rorsman C, Ronnstrand L, Heldin CH, Waltenberger J, Bohmer FD, Levitzki A 1994 Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation. Cancer Res 54:6406-6414
25. Osherov N, Levitzki A 1994 Epidermal-growth-factor-dependent activation of the src-family kinases. Eur J Biochem 225:1047-1053
26. Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, Leeder JS, Freedman M, Cohen A, Gazit A, Levitzki A, Roifman CM 1996 Inhibition of acute lymphobastic leukaemia by a Jak-2 inhibitor. Nature 379:645-648
27. Akiyama T, Ogawara H 1991 Use and specificity of genistein as inhibitor of protein-tyrosine kinases. Methods Enzymol 201:362-370
28. Umezawa K, Imoto M 1991 Use of erbstatin as protein-tyrosine kinase inhibitor. Methods Enzymol 201:379-385
29. Posner I, Engel M, Gazit A, Levitzki A 1994 Kinetics of inhibition by tyrphostins of the tyrosine kinase activity of the epidermal growth factor receptor and analysis by a new computer program. Mol Pharmacol 45:673-683